Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-supplemented analgesia and postoperative delirium in elderly cancer surgery patients
jRCTs021200016Completed
- Sponsor
- Funding of department of anesthesiology
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial in postoperative pain, postoperative delirium (POD) and solid organ cancer comparing Dexmedetomidine + morphine PCIA with Morphine-only PCIA (placebo for dexmedetomidine) (2 arms). Primary endpoint: Postoperative delirium incidence (first 5 days). Started Aug 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painpostoperative delirium (POD)solid organ cancer
Beyond the preview
Go deeper on jRCTs021200016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021200016.